| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02ac9bd35856d8efcae5699b55f9a19c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-332 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-23 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-31 |
| filingDate |
2014-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7168717e353b1dfe2dbd1c1a96902334
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eba2d6be5e5251c14df68715e6eaf797
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ece0abde7da86af7ea3b0aa8939a523b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abefbeeebf1cff760d7f4f132ff067be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc295012835fcc672d2d8a8db7a398ce |
| publicationDate |
2014-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20140022940-A |
| titleOfInvention |
ＨＴＲＰＡ１ activating composition comprising cruciferous or acid-type plant extracts and uses thereof |
| abstract |
The present invention provides a variety of uses associated with increasing hTRPA1 activity of compositions comprising cruciferous or antagonist plant extracts, such as irritant flavours, anti-obesity agents and hTRPA1 antagonist screening. The cruciferous or antagonist plant extract of the present invention provides a variety of uses related to hTRPA1 activation and is a natural compound with relatively low side effects and high industrial applicability to the human body. The cruciferous or antagonist plant extract of the present invention is not only a novel medicine or food material that helps maintain homeostasis in humans associated with the activation of hTRPA1, but can be usefully used for screening antagonists of hTRPA1. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020109065-A |
| priorityDate |
2014-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |